BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

14 related articles for article (PubMed ID: 38684373)

  • 1. Recombinant hirudin suppresses the viability, adhesion, migration and invasion of Hep-2 human laryngeal cancer cells.
    Lu Q; Lv M; Xu E; Shao F; Feng Y; Yang J; Shi L
    Oncol Rep; 2015 Mar; 33(3):1358-64. PubMed ID: 25592110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of MELK Inhibitor OTSSP167 on Diffuse Large B-Cell Lymphoma].
    Zhou JY; Huang H; Zhuang Y; Zhong XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):739-745. PubMed ID: 37356934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth.
    Haery L; Lugo-Picó JG; Henry RA; Andrews AJ; Gilmore TD
    Mol Cancer; 2014 Feb; 13():29. PubMed ID: 24529102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of breast cancer in female mice.
    Gu JW; Young E; Busby B; Covington J; Johnson JW
    Cancer Biol Ther; 2009 Mar; 8(6):514-21. PubMed ID: 19242105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic-AMP signalling, MYC and hypoxia-inducible factor 1α intersect to regulate angiogenesis in B-cell lymphoma.
    Ethiraj P; Sasi B; Holder KN; Lin AP; Qiu Z; Jaafar C; Elkhalili A; Desai P; Saksena A; Ritter JP; Aguiar RCT
    Br J Haematol; 2022 Jul; 198(2):349-359. PubMed ID: 35411936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant hirudin suppresses angiogenesis of diffuse large B-cell lymphoma through regulation of the PAR-1-VEGF.
    Zhao J; Li Z; Zhang H; Qin T; Zhao J; Pei Q
    Chem Biol Drug Des; 2024 May; 103(5):e14533. PubMed ID: 38684373
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.